Connect your AI

Adaptive Biotechnologies ADPT Shares (Basic)

Shares (Basic) at other companies

Guardant HealthGH

131.3M+6.0%

Natera, Inc.NTRA

141.5M+5.0%

Monte Rosa Therapeutics, Inc.GLUE

99.9M+21.6%

GeneDx HoldingsWGS

29.3M+4.2%

VeracyteVCYT

79.5M+1.9%

Nurix Therapeutics, Inc.NRIX

110.1M+31.7%

Other financials

Income statement

Revenue$70.9M+35.1%

Gross profit$52.2M+47.1%

Operating income-$19.2M+35.1%

Net income-$20.0M+32.9%

EPS (diluted)-$0.13+35.0%

Balance sheet

Cash & equivalents$77.6M+53.2%

Total debt$208.2M-5.6%

Total equity$216.3M+13.6%

Total assets$505.9M-1.0%

Cash flow

Operating cash flow-$9.5M+66.5%

CapEx$796.0K-36.8%

Free cash flow-$10.3M+65.3%

Valuation

Market cap$2.76B+93.6%

Enterprise value$2.89B+78.0%

P/S9.3×+1.8×

Profitability

Gross margin75.3%+12.7pp

Operating margin-15.8%-7.0pp

Net margin-16.8%-7.3pp

FCF margin-10.5%-4.6pp

Returns & leverage

Return on equity-24.4%-9.2pp

Debt / equity1×-0.2×

Current ratio3.4×+0.4×

Where this comes from

Reported directly by Adaptive Biotechnologies in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Adaptive Biotechnologies's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Adaptive Biotechnologies's shares (basic)?: Adaptive Biotechnologies (ADPT) reported shares (basic) of 155.5M in Q1 2026.
How has Adaptive Biotechnologies's shares (basic) changed year-over-year?: Adaptive Biotechnologies's shares (basic) increased by 4.2% year-over-year, from 149.2M to 155.5M.
What is the long-term trend for Adaptive Biotechnologies's shares (basic)?: Over 3 years (2022 to 2025), Adaptive Biotechnologies's shares (basic) has grown at a 2.1% compound annual growth rate (CAGR), from 569.5M to 605.4M.
What does shares (basic) mean?: The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.